Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin for focal cancer pain after surgery or radiation
NCT01931865Phase 2Terminated
- Sponsor
- Yale University
- Start
- Sep 2012
- Primary completion
- Jun 2015
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in cancer pain, sponsored by Yale University. Started Sep 2012; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT01931865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01931865.